Correlation of low molecular weight advanced glycation end products and nitric oxide metabolites with chronic complications in type 1 diabetic patients

Central European Journal of Biology

Volumn 3, Issue 3, 2008, Pages 243-249

  Heltianu, Constantina ^a   Manea, Simona Adriana ^a   Guja, Cristian ^b   Mihai, Carina ^c   Ionescu Tirgoviste, Constantin ^b  

^a INSTITUTE OF CELLULAR BIOLOGY AND PATHOLOGY NICOLAE SIMIONESCU   (Romania)

^b Institute of Diabetes   (Romania)

^c CAROL DAVILA UNIVERSITY OF MEDICINE AND PHARMACY   (Romania)

Author keywords

Low molecular weight AGEs; Neuropathy; Nitric oxide; Renal function; Type 1 diabetes

Indexed keywords

EID: 47349103758     PISSN: 1895104X     EISSN: 16443632     Source Type: Journal    
DOI: 10.2478/s11535-008-0019-4     Document Type: Article

References (16)

1. Wada R., Yagihashi S., Role of advanced glycation end products and their receptors in development of diabetic neuropathy, Ann. N.Y. Acad Sci., 2005, 1043, 598-604
2. Jakus V., Rietbrock N., Advanced glycation endproducts and the progress of diabetic vascular complications, Physiol. Res., 2004, 53, 131-142
3. Zilin S., Naifeng L., Bicheng L., Jiping W., The determination of AGE-peptides by flow injection assay, a practical marker of diabetic nephropathy, Clin. Chim. Acta, 2001, 313, 69-75
4. Deuther-Conrad W., Franke S., Henle T., Sommer M., Stein G., In vitro-prepared advanced glycation end-products and the modulating potential of their low-molecular weight degradation products in IRPTC-A rat proximal-tubular derived kidney epithelial cell line, Cell. Mol Biol (Noisy-le-grand.), 2001, 47, OL187-OL196
5. Meerwaldt R., Links T.P., Graaff R., Hoogenberg K., Lefrandt J.D., Baynes J.W., et al., Increased accumulation of skin advanced glycation end-products precedes and correlates with clinical manifestation of diabetic neuropathy, Diabetologia, 2005, 48, 1637-1644
6. Sharp P.S., Rainbow S., Mukherjee S., Serum levels of low molecular weight advanced glycation end products in diabetic subjects, Diabet. Med., 2003, 20, 575-579
7. Thomas M.C., Tsalamandris C., MacIsaac R., Medley T., Kingwell B., Cooper M.E., et al., Low-molecular-weight AGEs are associated with GFR and anemia in patients with type 2 diabetes, Kidney Int., 2004, 66, 1167-1172
8. Januszewski A.S., Thomas M.C., Chung S.J., Karschimkus C.S., Rowley K.G., Nelson C., et al., Plasma low-molecular weight fluorescence in type 1 diabetes mellitus, Ann. N.Y. Acad. Sci., 2005, 1043, 655-661
9. Makita Z., Radoff S., Rayfield E.J., Yang Z., Skolnik E., Delaney V., et al., Advanced glycosylation end products in patients with diabetic nephropathy, N. Engl. J. Med., 1991, 325, 836-842
10. Izumi N., Naqaoka T., Mori F., Sato E., Takahashi A., Yoshida A., Relation between plasma nitric oxide levels and diabetic retinopathy, Jpn J. Ophtmalmol., 2006, 50, 465-468
11. Zochodne D.W., Levy D., Nitric oxide in damage, disease and repair of the peripheral nervous system, Cell. Mol Biol (Noisy-le-grand), 2005, 51, 255-267
12. Cellek S., Qu W., Schmidt A.M., Moncada S., Synergistic action of advanced glycation end products and endogenous nitric oxide leads to neuronal apoptosis in vitro: a new insight into selective nitrergic neuropathy in diabetes, Diabetologia, 2004, 47, 331-339
13. Guja C., Ionescu-Tirgoviste C., Chronic angiopathic complications in type 1 diabetes across Europe as a result of EURODIAB multicentric study, In: Simionescu M., Sima A., Popov D. (Eds), Cellular dysfunction in atherosclerosis and diabetes-reports from bench to bedside, Romanian Academy Publishing House, Bucharest, 2004, 408-421
14. Wagner Z., Wittmann I., Mazak I., Schinzel R., Heidland A., Kientsch-Engel R., et al., N(epsilon)-(carboxymethyl)lysine levels in patients with type 2 diabetes: role of renal function, Am. J. Kidney Dis., 2001, 38, 785-791
15. Toshihiko T., Keitaro Y., Tomoko A., Fumi T., Sigeko H., Akira Y., et al., Evidence of association of the ecNOS gene polymorphism with plasma NO metabolite levels in humans, Biochem. Biophys. Res. Comm., 1998, 245, 190-193
16. Schalkwijk C.G., Ter Wee P.M., Stehouwer C.D., Plasma levels of AGE peptides in type 1 diabetic patients are associated with serum creatinine and not with albumin excretion rate: possible role of AGE peptide-associated endothelial dysfunction, Ann. N.Y. Acad. Sci., 2005, 1043, 662-670